Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: J Child Psychol Psychiatry. 2017 Oct 24;59(6):628–636. doi: 10.1111/jcpp.12830

Table 1.

Sample Demographics and Clinical Characteristics. Different letter subscripts signify statistically differences between groups.

Total (N = 95) Combined (n = 22) PEP (n = 26) Ω3 (n = 23) PBO (n = 24)

M ± SD or n (%)
Age 11.2 ± 2.2 11.0 ± 2.1 11.2 ± 2.3 11.7 ± 2.0 11.0 ± 2.5
Sex: Male 54 (56.8) 14 (63.6)ab 10 (38.5)b 11 (47.8)ab 19 (79.2)a
Race
 White 58 (61.1) 14 (63.6) 18 (69.2) 9 (39.1) 17 (70.8)
 Black/African-American 25 (26.3) 6 (27.3) 5 (19.2) 9 (39.1) 5 (20.8)
 Asian 1 (1.1) 1 (4.5) 0 (0.0) 0 (0.0) 0 (0.0)
 Biracial/Multiracial 11 (11.6) 1 (4.5) 3 (11.5) 5 (21.7) 2 (8.3)
Ethnicity: Hispanic 7 (7.4) 4 (18.2) 2 (7.7) 0 (0.0) 1 (4.2)
IQ 103 ± 16 105 ± 15 106 ± 16 98 ± 15 104 ± 15
Diagnoses
 Depressive Disorder* 72 (75.8) 17 (77.3) 19 (73.1) 18 (78.3) 18 (75.0)
 Bipolar Disorder NOS/Cyclothymic Disorder 23 (24.2) 5 (22.7) 7 (26.9) 5 (21.7) 6 (25.0)
 Comorbid Anxiety 73 (76.8) 17 (77.3) 21 (80.8) 16 (69.6) 19 (79.2)
 Comorbid ADHD 58 (61.1) 12 (54.5) 17 (65.4) 11 (47.8) 18 (75.0)
 Comorbid DBD 37 (38.9) 9 (40.9) 10 (38.5) 8 (34.8) 10 (41.7)
Medicaid Status 32 (33.7) 3 (13.6) 8 (30.8) 11 (47.8) 10 (41.7)

Parent Relationship
 Mother 86 (90.5) 21 (95.5) 25 (96.2) 20 (87.0) 20 (83.3)
 Father 5 (5.3) 1 (4.5) 0 (0.0) 3 (13.0) 1 (4.2)
 Grandmother 4 (4.2) 0 (0.0) 1 (3.8) 0 (0.0) 3 (12.5)
Parent Age 41.2 ± 8.0 43.0 ± 8.4 40.8 ± 6.7 39.7 ± 6.7 41.4 ± 9.8
Parent Race
 White 62 (65.3) 16 (72.7) 19 (73.1) 9 (39.2) 18 (75.0)
 Black/African American 27 (28.3) 6 (27.3) 4 (15.4) 11 (47.8) 6 (25.0)
 Asian 1 (1.1) 0 (0.0) 1 (3.8) 0 (0.0) 0 (0.0)
 Biracial/Multiracial 4 (4.2) 0 (0.0) 2 (7.7) 2 (8.7) 0 (0.0)
 Not reported 1 (1.1) 0 (0.0) 0 (0.0) 1 (4.3) 0 (0.0)
Parent Ethnicity: Hispanic 4 (4.2) 1 (4.5) 2 (7.7) 0 (0.0) 1 (4.2)
 Not reported 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.3) 0 (0.0)

PEP = Psychoeducational Psychotherapy + placebo; Ω3 = Omega-3 Monotherapy; PBO = Placebo alone; ADHD = Attention-Deficit/Hyperactivity Disorder; DBD = Disruptive Behavior Disorder.

*

Depressive disorder included major depression, dysthymia, or depressive disorder not otherwise specified as diagnosed at screening assessment.